ライフサイエンスコーパス: CT scan

1 e)/(time to 72-hour CT scan time to baseline CT scan).

2 re noted to be indeterminate on at least one CT scan).

3 the subset of individuals with an abdominal CT scan.

4 the generated pseudo CT scan to an acquired CT scan.

5 er with parenchymal haemorrhage on the first CT scan.

6 their exact location on the high-resolution CT scan.

7 aking, clinical findings, and a high-quality CT scan.

8 motherapy, and then underwent an interim PET-CT scan.

9 factor PCC within 1 h after initial cerebral CT scan.

10 as confirmed by a postoperative stereotactic CT scan.

11 s as a contraindication for LP without prior CT scan.

12 omplicated acute appendicitis confirmed by a CT scan.

13 nderwent (223)Ra and a baseline fluoride PET/CT scan.

14 based on the unenhanced CT images of the PET/CT scan.

15 nsfield units deviated from the real patient CT scan.

16 nd underwent a high-pitch spiral acquisition CT scan.

17 CT scores were assessed using the admission CT scans.

18 nd had undergone 4 consecutive (18)F-FDG PET/CT scans.

19 level of the pulmonary artery bifurcation on CT scans.

20 volume can be measured based on predonation CT scans.

21 ns for disagreement in the interpretation of CT scans.

22 sus group recommendations and reassessed the CT scans.

23 e common, often incidental findings on chest CT scans.

24 difficult and many centers rely heavily upon CT scans.

25 core 1 on MR images and as score 43 (68%) on CT scans.

26 core 1 on MR images and as score 45 (71%) on CT scans.

27 or masses were delineated from corresponding CT scans.

28 l of 313 fourth and subsequent follow-up PET/CT scans.

29 d at least 2 infection foci on (18)F-FDG PET/CT scans.

30 on the interpretation of (68)Ga-DOTATATE PET/CT scans.

31 sion-weighted images after coregistration to CT scans.

32 cans were obtained for 12 patients after PET/CT scans.

33 egment in zone I (414-474 mm) existed in all CT scans.

34 cases of NSCLC with preoperative thin-slice CT scans.

35 scores of maxillofacial computed tomography (CT) scans.

36 atients diagnosed with NSCLC underwent 2 PET/CT scans (1-3 d apart) before radiation therapy: a 3-min

37 metry were assessed by serial whole-body PET/CT scans (10 min, 1 h, and 2 h after injection).

38 There were 65 abnormal CT scans (10.3%) in the intoxicated group.

39 d a prospective multicenter study of FDG-PET/CT scanning 12 weeks after CCRT in newly diagnosed patie

40 c antigen values obtained at the time of PET/CT scan, 2.42 ng/mL; range, 0.61-27.56 ng/mL) who underw

41 ent 2 whole-body (test-retest) (18)F-NaF PET/CT scans 3 +/- 2 d apart from 1 of 3 imaging sites.

42 ponse by 2 target lesions on triphasic liver CT scans 3 mo after therapy, as assessed using RECIST, v

43 piratory system (EELV-Cst,rs); as well as by CT scan: (3) decrease in noninflated lung tissue (CT [no

44 35%) participants did not have ILA on either CT scan, 37 (2%) had stable to improving ILA, and 118 (6

45 Among 567 normal CT scans, 4 (0.7%) had central cord syndrome found on in

46 There were 59 CT scans (59/847=6.97%) and 14 MRI studies (14/269=5.20%

47 AVORY registry), 890 [96%] had interpretable CT scans (626 [70%] in the RESOLVE registry and 264 [30%

48 luded a native isotropic (0.6 mm) diagnostic CT scan (80 kV, 165 mAs) and a subsequent PET scan (2 mi

49 The radiologists assessed 799 referrals for CT scans (847 examinations of a particular part of the b

50 atients (83.7%) who underwent an interim PET-CT scan according to protocol had negative findings.

51 The CT scans acquired for PET attenuation-correction purpose

52 -125 tests alone and $16194647 per year with CT scans added.

53 odine therapy, patients underwent serial PET/CT scanning after administration of 20-40 MBq of (124)I.

54 of 1,659 fourth or subsequent follow-up PET/CT scans after completion of primary treatment.

55 of 1,659 fourth or subsequent follow-up PET/CT scans after completion of primary treatment.

56 (P < .001) for patients who had interim PET/CT scans after two cycles of R-CHOP-14 and 24% versus 72

57 was verified by printing the initial patient CT scan again after application of the gray-scale-correc

58 Spine clearance based on a normal CT scan among intoxicated patients with no gross motor d

59 llion Americans underwent at least one chest CT scan and 1.57 million had a nodule identified, includ

60 66.3%) did not have an indication for a head CT scan and 207 (33.7%) did.

61 Head CT scan and brain MRI showed a huge intra-axial right te

62 ontrols underwent a 27-min (11)C-acetate PET/CT scan and cardiac MRI (CMR).

63 est were drawn around multiple organs on the CT scan and copied to the PET scans.

64 nterval between baseline (68)Ga-DOTATATE PET/CT scan and follow-up imaging (14.0 +/- 6.1 months; rang

65 l, we recruited patients who had undergone a CT scan and had suspected stage I to IIIA lung cancer, f

66 confidence of the interpretation of the PET/CT scan and influences the SUV.

67 atients can be accurately digitized by micro-CT scan and that one can make digital cast model from mi

68 The bony metastases were not evident on the CT scan and the soft tissue mass was out of the coverage

69 r sample preparation, tissue staining, micro-CT scanning and 3D reconstruction, followed by a method

70 was calculated from preoperative 18F-FDG PET/CT scans and analyzed as marker of biochemical response

71 Whole-body PET/CT scans and blood samples were obtained at 1, 24, 48, 9

72 Conventional linear-blended CT scans and corresponding virtual noncalcium reconstruc

73 as an add-on to visual analysis of PSMA PET/CT scans and has the potential to reduce turnaround time

74 asis of clinical symptoms and, if available, CT scans and lung biopsies.

75 aracterized by image analyses of X-ray micro-CT scans and N2 adsorption.

76 e negative predictive value (NPV) of FDG-PET/CT scans and other supporting diagnostic test characteri

77 ng standardized and centrally read abdominal CT scans and whole-body dual-energy absorptiometry scans

78 ion on the basis of the computer tomography (CT) scan and magnetic resonance imaging (MRI) of the ost

79 ection abdominal-pelvic computed tomography (CT) scan and optical colonoscopy (OC).

80 vasation was present, a computed tomography (CT) scan and upper endoscopy were performed.

81 mography-computed tomography ([(18)F]FDG/PET-CT) scans and its added value to these models.

82 mptoms of anastomotic leakage are present, a CT-scan and endoscopy are currently the methods of choic

83 Based on CT-scans and upper endoscopy, the true number of anastom

84 intraperitoneal fluid found on an abdominal CT scan, and 9 patients (0.97%; 95% CI, 0.44% to 1.8%) u

85 h measurable lymph node disease (>1.5 cm) by CT scan, and had relapsed or refractory disease followin

86 ce of traumatic intracranial lesions on head CT scan, and neurosurgical intervention.

87 mputed tomography (SPECT)/CT and multiphasic CT scan, and/or magnetic resonance imaging in a blinded

88 Retrospective analysis of serial CT scans, and clinical data for a case-control series we

89 of which contain X-ray, computed tomography (CT) scan, and genomic data, respectively.

90 Because of CT scan, antibiotics were initiated in 51 (16%) and disc

91 ts who had serial chest computed tomography (CT) scans approximately 6 years apart.

92 clusion Adrenal calcifications identified on CT scans are common in patients with fCCM and may be a c

93 prior to data collection were that cervical CT scans are sensitive and specific enough to diagnose C

94 Conclusion PFP changes on CT scans are significantly associated with injuries of P

95 Conclusions and Relevance: CA-125 tests and CT scans are still routinely used for surveillance testi

96 s that require stabilization and that normal CT scans are sufficient to clear CSIs in intoxicated pat

97 nt guidelines exist for the acquisition of a CT scan as part of pediatric PET/CT.

98 went a preoperative whole-body (18)F-FDG PET/CT scan at 1 h (standard examination) and an additional

99 omethylcholine, followed by a whole-body PET/CT scan at 40 min.

100 f 2,312 participants who underwent full-lung CT scanning at 10-year follow-up.

101 bdominal 45-min dynamic and 3 whole-body PET/CT scans at 1, 2, and 4 h after injection of a low pepti

102 cessive whole-body (vertex to mid thigh) PET/CT scans at 3 time points (30, 60, and 120 min) were obt

103 ent double baseline whole-body (18)F-FDG PET/CT scans at 60 and 90 min after injection within 3 d.

104 rsus 72% (P < .001) for patients who had PET/CT scans at the end of treatment.

105 stem (VFALBIA) with computerized tomography (CT) scanned at the L4-L5 vertebrae (VFACT).

106 ed ninety patients had computed tomographic (CT) scans available for analysis of skeletal muscle (SM)

107 n = 133) underwent an adequate (18)F-FDG PET/CT scan before surgery between January 2003 and December

108 tumors and who underwent (68)Ga-DOTATATE PET/CT scanning before and after receiving long-acting repea

109 , 2012, to study the use of CA-125 tests and CT scans before and after 2009.

110 es and Measures: The use of CA-125 tests and CT scans before and after 2009.

111 positron emission tomography-CT or abdominal CT scans before and after RT and were included for analy

112 advanced EC and a pretreatment (18)F-FDG PET/CT scan between 2009 and 2015.

113 advanced EC and a pretreatment (18)F-FDG PET/CT scan between 2009 and 2015.

114 igament injury that was misread as normal on CT scan but was abnormal on magnetic resonance imaging.

115 isease was delineated on prechemotherapy PET-CT scans by 2 (1) manual contouring and (2) subthreshold

116 specimen and in 10 healthy subjects on spine CT scans by three radiologists (readers 1, 2, and 3) wor

117 Of the 1,258 (68)Ga-DOTATATE PET/CT scans completed, 75.7% were positive and 24.3% negati

118 The mean number of head CT scans conducted in the year after admission for strok

119 inhibitor bypassing activity and a follow-up CT scan confirmed hemostasis.

120 As air regions of the micro-CT scan data of dental impression are equivalent to the

121 Here, we show that by integrating CT scan data, the population model can be expanded to in

122 otal horn length using high-resolution X-ray CT scanning data, relative testes mass, and male-male ag

123 enhanced abdominopelvic computed tomography (CT) scan demonstrated a mass in the pancreatic body that

124 Conclusion:(68)Ga-PSMA PET/CT scans detect previously unsuspected disease and may i

125 Three-month (18)F-FDG PET/CT scans detected HL patients responding to anti-PD1.

126 We analysed all CT scans, echocardiograms, and neurological events in a

127 ission tomography (PET)/computed tomography (CT), scanning electron microscopy (SEM), and transition

128 MI, exacerbations within 1 year before index CT scan, FEV1/FVC, and chronic P aeruginosa infection (1

129 secondary to ischemia of the bowel wall with CT scan findings aid in establishing the diagnosis of st

130 Physical examination and CT scan findings were evaluated for cervical spine injur

131 Even when controlling for age/medication/CT scan findings, fixation remained a significant predic

132 CT scanning followed by AVS was a cost-effective strateg

133 stem-detected nodules that were rejected per CT scan for CAD systems 1-4 at time 0 was 7.4, 1.7, 0.6,

134 function, the limited resolution of clinical CT scanning for microscopic changes to the lung architec

135 ent data and centrally reviewed baseline PET-CT scans for 185 patients with FL who were receiving imm

136 PET/CT scans for dosimetry assessment were obtained at 10, 6

137 ng levels of experience evaluated gray-scale CT scans for the presence of fractures and their suspect

138 The added value of each follow-up PET/CT scan, for clinical assessment and the treatment chang

139 We analyzed 2,854 (18)F-FDG PET/CT scans from 1,644 patients and identified 98 scans fro

140 bolic activity was measured on (18)F-FDG PET/CT scans from day 7 to day 24 after instillation, with a

141 years and older who underwent cervical spine CT scans from March 2014 to March 2015 at an American Co

142 Admission abdominopelvic CT scans from patients 65 years and older admitted to th

143 CT scans from the Australian Respiratory Early Surveilla

144 I (236-256 mm) existed in 99.6% and 97.9% of CT scans from the right and left femoral arteries, respe

145 ve study of whole-body computed tomographic (CT) scans from a cohort of 280 consecutive civilian trau

146 ach to generate pseudo computed tomographic (CT) scans from MR images.

147 ivity in blood, followed by 4 whole-body PET/CT scans, from the vertex to the mid thigh, at 10, 60, 1

148 Our results confirmed that an interim PET/CT scan has limited prognostic value in patients with di

149 (68)Ga-PSMA PET/CT scanning has been shown to be more sensitive than con

150 standard error 20%) between two consecutive CT scans (i.e., 6-8 weeks) gives a probability of diseas

151 An additional preradiotherapy/CCRT PET/CT scan improves both DFS and DSS in patients with advan

152 The produced phantom was subject to further CT scan in comparison with that of the patient data for

153 ly for the prediction of response on a later CT scan in erlotinib-treated non-small cell lung cancer

154 e authors retrospectively reviewed abdominal CT scans in 38 patients with fCCM, 38 unaffected age- an

155 s measured at baseline and on serial cardiac CT scans in 5,702 participants.

156 lines of the Quality Improvement Registry in CT Scans in Children were retrieved from a national dose

157 d as a solid nodule on computed tomographic (CT) scans in annual rounds of screening (time 1) were re

158 se of CA-125 tests and computed tomographic (CT) scans in clinical practice before and after the 2009

159 olumes were measured on computed tomography (CT) scans in the BPES sample and in a group of age-match

160 were rate of abdominal computed tomographic (CT) scans in the ED, missed intra-abdominal injuries, ED

161 both (68)Ga-DOTATOC and (64)Cu-DOTATATE PET/CT scans, in random order.

162 Patients with a CT scan indication were older, had more comorbidities, w

163 erver reproducibility of (68)Ga-DOTATATE PET/CT scan interpretation was measured between blinded and

164 additional value, except when a double-zero CT scan is present or when the subjects are already at h

165 (68)Ga-DOTATATE PET/CT scanning is a widely accepted method for imaging of n

166 (68)Ga-DOTATATE PET/CT scanning is safe and influences management in a large

167 Overall, (68)Ga-PSMA PET/CT scanning led to a change in planned management in 51%

168 At diagnosis, 19.6% of (18)F-FDG PET/CT scans led to treatment modification.

169 f iMAR depends on the indication for the PET/CT scan, location and size/type of the prosthesis, and l

170 The CT scan measures the amount of collapsed tissue that reg

171 c recovery coefficient based on the low-dose CT scan, method 3 was an enlarged volume of interest inc

172 CT scan modified classification in 187 (58.6%; 95% confi

173 and the resulting response categories from a CT scan obtained after 9-11 wk of erlotinib treatment us

174 The fourth and subsequent PET/CT scans obtained after completion of primary treatment

175 Conclusion: The fourth and subsequent PET/CT scans obtained after completion of primary treatment

176 rihematomal edema volumes were measured from CT scans obtained at presentation, 24-hours, and 72-hour

177 ors retrospectively reviewed preoperative 4D CT scans obtained from November 2012 to June 2014 in 94

178 o demonstrate the feasibility of using micro-CT scan of dental impressions for fabricating dental res

179 CT scan of the abdomen confirmed multiple hypervascular

180 Each set consisted of a 30-min dynamic PET/CT scan of the chest after intravenous administration of

181 The patient initially had a CT scan of the lumbar spine which only revealed a protru

182 d a whole-body scintigraphy scan and a SPECT/CT scan of the neck to distinguish between metastatic an

183 CT scan of the temporal bone and surgery were performed

184 (18)F-FDG PET/CT scans of 14 patients with metal implants (either dent

185 muscle) was estimated on 177Lu-DOTATOC SPECT/CT scans of 15 patients affected by NET with different l

186 -specific membrane antigen ((68)Ga-PSMA) PET/CT scans of 7 patients with hip prostheses were scored b

187 Here, we used micro-CT scans of extant mammals (47 species) and birds (59 sp

188 ss its biodistribution properties, SPECT and CT scans of HT29-xenografted nude mice injected with (17

189 his hypothesis, we reviewed pretreatment PET-CT scans of patients with stage I-II HL treated at our i

190 aterial/A retrospective analysis included 44 CT scans of the paranasal sinuses that were performed in

191 A subsequent computed tomography (CT) scan of the chest with contrast revealed a large con

192 criteria for the use of computed tomography (CT) scan of the head before lumbar puncture (LP) in adul

193 Clinic who underwent a computed tomographic (CT) scan of the kidney with the use of contrast material

194 sion tomography/computed tomography (FDG-PET/CT) scan of the neck in locoregionally advanced head-and

195 Computerized tomography (CT) scanning of the brain is essential for diagnostic sc

196 lity on chest x-rays or computed tomography (CT) scans of the lungs.

197 X-ray computer-aided tomography (CT) scans of the moths did not reveal any internal coupl

198 nation and the consensus group assessment of CT scans on the presence/absence of a ventral hernia in

199 nt two sets of (18)F-fluoromethylcholine PET/CT scans, on consecutive days.

200 s the optimal predictor of response on later CT scans, outperforming both SULpeak and SULmax The use

201 At visit 1, a dynamic PET/CT scan over the kidney was obtained during the first 30

202 overage includes 3 posttherapy (18)F-FDG PET/CT scans per patient and per tumor type.

203 Retrospective review of 45,680 PET/CT scans performed at a comprehensive cancer center from

204 (mCRPC) with osseous metastases had NaF PET/CT scans performed at baseline and after three cycles of

205 Of all (18)F-FDG PET/CT scans performed at diagnosis, 13.5% led to a change i

206 Of the 41,538 PET/CT scans performed during the study period, 303 (0.7 %)

207 there was a mean of 4.6 CA-125 tests and 1.7 CT scans performed per patient, resulting in a US popula

208 atients underwent a preradiotherapy/CCRT PET/CT scan (PET group), and 522 did not (NO-PET group).

209 After completion of the CT scan, pO2 probe measurements were performed along eac

210 All patients had at least three cranial CT scans prior to the surgery.

211 ine CT brain examinations, and to assess how CT scanning protocols affect patient doses in practice.

212 Hodgkin's lymphoma underwent a baseline PET-CT scan, received two cycles of ABVD (doxorubicin, bleom

213 mary tumour, WHO performance status, 16-week CT scan result, number of metastatic sites, and first-li

214 The PET/CT scan resulted in a treatment change in 28.1% (80/285)

215 ourth and subsequent follow-up (18)F-FDG PET/CT scans resulted in change in management in 31.6% of th

216 During follow-up, 57.3% of (18)F-FDG PET/CT scans resulted in treatment modification.

217 aire was completed after the (68)Ga-PSMA PET/CT scan results were available to determine whether the

218 The follow-up PET/CT scan results were correlated with clinical assessment

219 nts who had positive (68)Ga-HBED-PSMA-11 PET/CT scanning results and underwent comparative (68)Ga-THP

220 structions provided by high-resolution micro-CT scans reveal how male and female molecules and anatom

221 Abdominal CT scan revealed large amount of retained stool in the c

222 Follow-up CT scans revealed a total exclusion of the aneurysm from

223 Retrospective review of CT scans revealed more grade 1 and 2 thromboses than wer

224 Chest computed tomography (CT) scan revealed a 2.5-cm mass in the right upper lobe

225 expression of PD-1 correlated with the total CT scan scores (r = 0.5, P = 0.02).

226 CT scan showed a low-attenuation lesion at the inner wal

227 The CT scan showed scalloping over the right supra-orbital r

228 allows generation of discrete-valued pseudo CT scans (soft tissue, bone, and air) from a single high

229 were randomized to have five annual low-dose CT scans (study group) or no screening (control group).

230 emission tomography-computed tomography (PET-CT) scans, such as metabolic tumor volume (MTV) and tota

231 High-resolution CT scans suggest areas of the skull are affected differe

232 fourth or additional follow-up (18)F-FDG PET/CT scans that could affect the management of patients.

233 d 74.4% had negative findings on a third PET-CT scan; the 3-year progression-free survival rate was 6

234 Of 100 CT scans, there was disagreement among all 9 reviewers a

235 arable to having acquired a patient-specific CT scan, thus improving the results obtained with the ul

236 t 72 hours PHE at baseline)/(time to 72-hour CT scan time to baseline CT scan).

237 in retrospect, be identified on the previous CT scans (time 0).

238 0 patients by comparing the generated pseudo CT scan to an acquired CT scan.

239 We used clinically obtained CT scans to measure volumes of the ventricles, intracran

240 he use of opportunistic computed tomography (CT) scans to assess sarcopenia and osteopenia as indicat

241 n Tomography Computed Tomography (18-FDG PET/CT) scans to assess vascular inflammation (VI) and coron

242 , MRI, and a 210-min (18)F-GE180 dynamic PET/CT scan using metabolite-corrected arterial plasma input

243 from Regions Of Interest (ROI) delineated on CT-scan using TexRAD software.

244 To determine reader and computed tomography (CT) scan variability for measurement of coronary plaque

245 Recruitment measured by CT scan was 5 +/- 5% (CT [not inflated]) and 6 +/- 6% (C

246 incidence of patients undergoing more than 1 CT scan was 81% in 2004-2009 vs 78% in 2010-2012 (P = .5

247 One hour after injection, a pelvic PET/CT scan was acquired for preoperative SLN mapping.

248 Owing to the high interobserver variability, CT scan was not associated with reliable diagnosing in v

249 March 2015, when at least one (18)F-FDG PET/CT scan was obtained.

250 A CT scan was ordered before the LP in 549 patients (89%).

251 The spatial information from the CT scan was used to segment the region corresponding to

252 The proportion of patients with abdominal CT scans was 241 of 460 (52.4%) in the FAST group and 25

253 or absence of a recurrent ventral hernia on CT scans was compared among 9 blinded reviewers and the

254 hite [89.6%]), the use of CA-125 testing and CT scans was similar during the study period.

255 Image analysis of CT scans was used to calculate Lumbar skeletal muscle in

256 ent changes subsequent to each follow-up PET/CT scan, was established.

257 forming a fourth or subsequent follow-up PET/CT scan were determined, and the impact of each of the 1

258 emic health care center with a postoperative CT scan were randomly selected from a larger cohort.

259 SPECT/CT scans were acquired at 1, 24, and 48 h after injectio

260 (18)F-FDG PET/CT and contrast-enhanced CT scans were acquired every 3 mo.

261 The PET/CT scans were also analyzed to determine tissue radioact

262 CT scans were assessed by local radiologists according t

263 egies utilizing 2 years of routine CT or PET/CT scans were associated with minimal survival benefit w

264 each patient, (18)F-FES and (18)F-4FMFES PET/CT scans were done sequentially (within a week) and in r

265 Triple-phase CT scans were graded independently by 2 radiologists as

266 s undergoing 78 (18)F-fluoroethylcholine PET/CT scans were identified for this study.

267 Two segments (1 per zone) common to all CT scans were isolated, and their location, length, prev

268 The results of (18)F-choline PET/CT scans were negative in 300 patients; 44% had a GS of

269 Whole-body PET/CT scans were obtained 1, 72, and 144 h after injection.

270 Methods:(18)F-FDG PET/CT scans were obtained before and after 7-10 d of erloti

271 CT scans were obtained every 24 h throughout dosing.

272 5 and August 2013, 1,258 (68)Ga-DOTATATE PET/CT scans were obtained in 728 patients with confirmed or

273 Routine CT scans were performed at baseline and every 3 mo there

274 All multi-detector row CT scans were performed at two different radiation dose

275 These whole-body CT scans were performed between 2013 and 2015.

276 The results of 645 PET/CT scans were positive for PCa recurrence.

277 The standard low-dose CT scans were processed with the iMAR algorithm.

278 (18)F-FDG PET/CT scans were prospectively reevaluated by 3 nuclear med

279 Immediate-postablation enhanced CT and PET/CT scans were qualitatively evaluated by 2 reviewers ind

280 Fifteen oncology body (18)F-FDG PET/CT scans were reconstructed using OSEM, OSEM PSF, and Q.

281 (at 3 h after injection) (68)Ga-PSMA-11 PET/CT scans were retrospectively evaluated.

282 cancerous lobe, which left 27 patients whose CT scans were reviewed by four radiologists: Group A (n

283 CT scans were scored for the presence of radiological ab

284 tations delineated by major fissures on both CT scans were used to calculate the percentage of ventil

285 both (64)Cu-DOTATATE and (68)Ga-DOTATOC PET/CT scans, whereas an additional 68 lesions were found by

286 both (64)Cu-DOTATATE and (68)Ga-DOTATOC PET/CT scans, whereas an additional 68 lesions were found by

287 Any additional follow-up (18)F-FDG PET/CT scans will be reimbursed at the discretion of a local

288 esults Deep MRAC provides an accurate pseudo CT scan with a mean Dice coefficient of 0.971 +/- 0.005

289 fy all participants with at least one NSN on CT scan with lung cancer as the cause of death (COD) doc

290 e, no study has correlated ONSD on admission CT scan with RCTS.

291 The subvolumes delineated on initial PET/CT scans with 30%-60% SUVmax thresholds were in good to

292 s of automated quantification of 38 PSMA PET/CT scans with different levels of bone involvement were

293 viewers (consensus group) met to discuss all CT scans with disagreement.

294 ients underwent 60-min dynamic (11)C-HED PET/CT scans with online arterial blood sampling.

295 ) patients underwent 4 or more follow-up PET/CT scans, with a total of 313 fourth and subsequent foll

296 e solid, part-solid and non-solid nodules in CT scans, with hierarchical features in each case learne

297 ceive an additional preradiotherapy/CCRT PET/CT scan within 1 wk of starting adjuvant therapy.

298 diseases, who underwent pelvic MRI-DIXON and CT scan within one year, were included.

299 Chest CT scan without intravenous contrast demonstrated no evi

300 isk of recurrence to reduce the frequency of CT scans without compromising surveillance benefits.